Iijima Kenji, Koike Hisashi, Ota Hiromi, Nakagawa Mayumi, Nishikawa Ken-Ichi, Kotani Kazuhiko
Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University Yonago 683-8503.
Rinsho Byori. 2008 Aug;56(8):678-83.
Nine clones of non-pathogenic streptococci were isolated from the pharynges of seven healthy subjects, and grown on sheep blood agar plates with a hemolysis or gamma hemolysis, then cultured in LB broth for 16 hrs. Purified streptolysin O (SLO) purchased from Sigma Chemical Co. (Sigma-SLO), SLO antigen as a latex agglutination reagent from A company (A-SLO) and supernatants from four culture media were electrophoresed on 12% SDS-polyacrylamide gel and transferred to PVDF membranes. Immunological analyses of antibodies against SLO in healthy sera and proteins in culture medium demonstrated that healthy sera contained an antibody recognizing Sigma-SLO, A-SLO and a protein of the same size as SLO (SLO-like protein) in culture medium. These findings suggest that healthy subjects develop an antibody directed against SLO-like protein produced by non-pathogenic streptococci, and that this antibody cross-reacts with Sigma-SLO and A-SLO. Using DNA from Streptococcus pyogenes and non-pathogenic streptococci, the SLO gene and SLO-like protein gene were analyzed by direct sequencing with oligonucleotide primers designed to cover no. 74 to approximately 1900 of the SLO gene. There were three different bases resulting in amino acid substitution between the SLO gene and SLO-like protein gene, namely 101Lys (AAA) of SLO to Asn (AAT), 175Met (ATG) to Arg (AGG) and 185Asp (GAT) to Asn (AAT). Remaining 560 residues of 563 amino acids constituting SLO-like protein were homologous to SLO. Non-pathogenic streptococci on the pharynges of healthy subjects produce an SLO-like protein composed of amino acids similar to those of SLO, which induces an antibody against this SLO-like protein in serum. It is likely that an antibody against SLO-like protein in healthy sera cross-reacts with SLO and causes a pseudo-positive reaction on ASO measurement by the latex agglutination method using SLO antigen.
从7名健康受试者的咽喉中分离出9株非致病性链球菌,将其接种于具有α溶血或γ溶血特性的羊血琼脂平板上,然后在LB肉汤中培养16小时。从Sigma化学公司购买的纯化链球菌溶血素O(SLO)(Sigma - SLO)、作为乳胶凝集试剂的来自A公司的SLO抗原(A - SLO)以及四种培养基的上清液在12% SDS - 聚丙烯酰胺凝胶上进行电泳,并转移至PVDF膜上。对健康血清中抗SLO抗体和培养基中蛋白质的免疫分析表明,健康血清中含有一种能识别Sigma - SLO、A - SLO以及培养基中与SLO大小相同的蛋白质(SLO样蛋白)的抗体。这些发现提示,健康受试者会产生针对非致病性链球菌产生的SLO样蛋白的抗体,并且该抗体与Sigma - SLO和A - SLO发生交叉反应。利用化脓性链球菌和非致病性链球菌的DNA,通过使用设计用于覆盖SLO基因第74位至约1900位的寡核苷酸引物进行直接测序,对SLO基因和SLO样蛋白基因进行了分析。SLO基因和SLO样蛋白基因之间存在三个导致氨基酸替换的不同碱基,即SLO的101位赖氨酸(AAA)替换为天冬酰胺(AAT)、175位甲硫氨酸(ATG)替换为精氨酸(AGG)以及185位天冬氨酸(GAT)替换为天冬酰胺(AAT)。构成SLO样蛋白的563个氨基酸中的其余560个残基与SLO同源。健康受试者咽喉中的非致病性链球菌产生一种由与SLO氨基酸相似的氨基酸组成的SLO样蛋白,该蛋白在血清中诱导产生针对这种SLO样蛋白的抗体。健康血清中针对SLO样蛋白的抗体很可能与SLO发生交叉反应,并在用SLO抗原通过乳胶凝集法进行抗链球菌溶血素O(ASO)检测时导致假阳性反应。